TriReme Medical, LLC is a medical device company founded in 2005 with a focus on developing, manufacturing, and distributing advanced therapeutic solutions for the treatment of complex vascular disease. The company is dedicated to addressing unmet clinical needs, collaborating with thought leaders and scientists globally to provide physicians with new and differentiated devices aimed at improving outcomes in complex peripheral and coronary interventions.
TriReme Medical, LLC operates as a subsidiary of QT Vascular Ltd., a parent holding company based in Singapore. The company's US subsidiary is located in Pleasanton, California. In November 2012, the company secured an $18.00M Series E investment led by Luminor Capital. QT Vascular Ltd. was listed on the Catalist Board of the Singapore Exchange Securities Trading Limited on 29 April 2014.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series E | $18.00M | 1 | Luminor Capital | 27 Nov 2012 |
| Series D | $17.00M | 3 |
|
11 Oct 2010 |
| Venture Round | $7.05M | - | 16 Nov 2009 | |
| Series C | $15.50M | 2 |
|
16 Oct 2007 |
| Series A | $1.37M | - | 12 Oct 2005 |
No recent news or press coverage available for TriReme Medical, LLC.
We care about your data, and we'd love to use cookies make your experience better.
